## Abstract MicroRNAs (mirs) are small noncoding RNA molecules (∼22 nucleotides) that regulate posttranscriptional gene expression. Currently, there has not been a comprehensive study of their role in primary head and neck squamous cell carcinoma (HNSCC). To determine the role of mirs in HNSCC, we
Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus
✍ Scribed by Abigail I. Wald; Elizabeth E. Hoskins; Susanne I. Wells; Robert L. Ferris; Saleem A. Khan
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 537 KB
- Volume
- 33
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
Human papillomavirus (HPV)‐positive cases of squamous cell carcinoma of the head and neck (SCCHN) have a much better disease outcome compared to SCCHN cases lacking HPV. Differences in microRNA (miRNA) expression may affect their clinical outcomes.
Methods
The miRNA expression was studied using microarrays and quantitative reverse transcriptase‐polymerase chain reaction (RT‐PCR) in HPV‐16‐positive and HPV‐negative SCCHN cell lines. The role of HPV‐16 E6 and E7 oncogenes in altering miRNA expression was investigated using human foreskin keratinocytes (HFKs).
Results
The miRNAs miR‐363, miR‐33, and miR‐497 were upregulated, whereas miR‐155, miR‐181a, miR‐181b, miR‐29a, miR‐218, miR‐222, miR‐221, and miR‐142‐5p were downregulated in HPV‐positive cells compared to both HPV‐negative SCCHN and normal oral keratinocytes. HPV‐16 E6 oncogene altered miRNA expression in HFKs and in an HPV‐16–positive cell line with E6 knockdown using siRNA.
Conclusion
miRNAs differentially expressed in the presence of HPV‐16 may provide biomarkers for SCCHN and identify cellular pathways targeted by this virus. © 2010 Wiley Periodicals, Inc. Head Neck, 2011
📜 SIMILAR VOLUMES
## Abstract ## Background The purpose of this study was to investigate the potential role of variable microRNA (miRNA) expression in the development of multidrug resistance (MDR) in head and neck cancer. ## Methods Head and neck squamous cell carcinoma cell lines UMSCC‐1 and SQ20B were treated w
## Abstract The role of human papillomavirus (HPV) in head and neck squamous cell carcinoma (HNSCC) development has been recognized only in the last decade. Although younger patients develop HNSCC associated with HPV, the incidence in young patients has not been studied. Forty‐five young HNSCC pati
## Abstract Fresh‐frozen biopsies were obtained from 61 patients at diagnosis of squamous cell carcinoma of the head and neck (HNSCC) for study of the prevalence and physical status of human papillomavirus (HPV) DNA. The frequency of HPV DNA and genotypes were determined by SPF10 PCR screening with
## Abstract ## __Background.__ We established multiple University of Michigan Squamous Cell Carcinoma (UM‐SCC) cell lines. With time, these have been distributed to other labs all over the world. Recent scientific discussions have noted the need to confirm the origin and identity of cell lines in